Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Chicago, IL
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Indianapolis, IN
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Indianapolis, IN
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Baltimore, MD
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Ann Arbor, MI
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
C S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Jackson, MS
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Kansas City, MO
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Saint Louis, MO
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Valhalla, NY
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Chapel Hill, NC
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Columbus, OH
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Philadelphia, PA
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Philadelphia, PA
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Children's Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Nashville, TN
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated:  2/19/2016
mi
from
Salt Lake City, UT
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors With and Without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631
Status: Enrolling
Updated: 2/19/2016
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated:  2/19/2016
mi
from
Duarte, CA
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated: 2/19/2016
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants
An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated:  2/19/2016
mi
from
Overland Park, KA
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants
An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 2/19/2016
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
mi
from
Beltsville, MD
USDA Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
An Open-label, Multiple Dose, Randomized, Three-period Crossover Study in Healthy Subjects to Evaluate the Effect of Co-administration of Oseltamivir (Ro 64-0796) 75 mg Twice Daily and Rimantadine 100 mg Twice Daily on the Pharmacokinetic Properties of Oseltamivir and Rimantadine.
Status: Enrolling
Updated:  2/19/2016
mi
from
Little Rock, AR
A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
An Open-label, Multiple Dose, Randomized, Three-period Crossover Study in Healthy Subjects to Evaluate the Effect of Co-administration of Oseltamivir (Ro 64-0796) 75 mg Twice Daily and Rimantadine 100 mg Twice Daily on the Pharmacokinetic Properties of Oseltamivir and Rimantadine.
Status: Enrolling
Updated: 2/19/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Magnetic Resonance (MR) Evaluation of the Effect of Erythromycin Upon Gastric and Small Bowel Motility
Status: Enrolling
Updated:  2/19/2016
mi
from
Rochester, MN
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Magnetic Resonance (MR) Evaluation of the Effect of Erythromycin Upon Gastric and Small Bowel Motility
Status: Enrolling
Updated: 2/19/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers
Status: Enrolling
Updated:  2/22/2016
mi
from
Cambridge, MA
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers
Status: Enrolling
Updated: 2/22/2016
Kaleido Biosciences
mi
from
Cambridge, MA
Click here to add this to my saved trials
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers
Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial
Status: Enrolling
Updated:  2/22/2016
mi
from
Madison, WI
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers
Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial
Status: Enrolling
Updated: 2/22/2016
1199.14.1186 Boehringer Ingelheim Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Psilocybin and Spiritual Practice
Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior
Status: Enrolling
Updated:  2/23/2016
mi
from
Baltimore, MD
Psilocybin and Spiritual Practice
Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior
Status: Enrolling
Updated: 2/23/2016
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Status: Enrolling
Updated:  2/23/2016
mi
from
Philadelphia, PA
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Status: Enrolling
Updated: 2/23/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CALERIE Phase II Ancillary: Metabolic
CALERIE Phase II Ancillary 2: Metabolic Adaptation After Two Years of Caloric Restriction in Non Obese Humans
Status: Enrolling
Updated:  2/24/2016
mi
from
Baton Rouge, LA
CALERIE Phase II Ancillary: Metabolic
CALERIE Phase II Ancillary 2: Metabolic Adaptation After Two Years of Caloric Restriction in Non Obese Humans
Status: Enrolling
Updated: 2/24/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Effect of AGE on the Immune System
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated:  2/25/2016
mi
from
Gainesville, FL
The Effect of AGE on the Immune System
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
Food Science & Human Nutrition Building, University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Effect of AGE on the Immune System
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated:  2/25/2016
mi
from
Gainesville, FL
The Effect of AGE on the Immune System
The Effect of Aged Garlic Extract Supplementation on the Immune System
Status: Enrolling
Updated: 2/25/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease
Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626
Status: Enrolling
Updated:  2/25/2016
mi
from
Glendale, CA
A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease
Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626
Status: Enrolling
Updated: 2/25/2016
California Clinical Trials Medical Group
mi
from
Glendale, CA
Click here to add this to my saved trials
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Status: Enrolling
Updated:  2/25/2016
mi
from
Kettering, OH
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Status: Enrolling
Updated: 2/25/2016
Kettering Medical Center
mi
from
Kettering, OH
Click here to add this to my saved trials
Neurobiological Bases of Paternal Nurturance
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated:  2/26/2016
mi
from
Atlanta, GA
Neurobiological Bases of Paternal Nurturance
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Neurobiological Bases of Paternal Nurturance
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated:  2/26/2016
mi
from
Atlanta, GA
Neurobiological Bases of Paternal Nurturance
Biological Bases of Individual Variation in Paternal Nurturance
Status: Enrolling
Updated: 2/26/2016
Emory University 1462 Clifton Rd
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated:  2/26/2016
mi
from
Miami, FL
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated:  2/26/2016
mi
from
Miami, FL
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers
A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
The Effect of Calorie Deprivation on Adipose Tissue Distribution
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Status: Enrolling
Updated:  2/27/2016
mi
from
Boston, MA
The Effect of Calorie Deprivation on Adipose Tissue Distribution
The Effect of Calorie Deprivation on Adipose Tissue Distribution
Status: Enrolling
Updated: 2/27/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oral Contraceptive DDI Study
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated:  2/29/2016
mi
from
Evansville, IN
Oral Contraceptive DDI Study
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Lexicon Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Oral Contraceptive DDI Study
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated:  2/29/2016
mi
from
Dallas, TX
Oral Contraceptive DDI Study
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status: Enrolling
Updated: 2/29/2016
Lexicon Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
Gene Environment Risk Assessment and CRC Screening
Status: Enrolling
Updated:  3/1/2016
mi
from
Philadelphia, PA
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
Gene Environment Risk Assessment and CRC Screening
Status: Enrolling
Updated: 3/1/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated:  3/1/2016
mi
from
Overland Park, KA
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated:  3/1/2016
mi
from
Minneapolis, MN
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated:  3/1/2016
mi
from
Boca Raton, FL
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated:  3/1/2016
mi
from
Raleigh, NC
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated:  3/1/2016
mi
from
Memphis, TN
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
An Online Study of the Reliability of the Brain Performance Test (BPT)
An Online Study of the Reliability of the Brain Performance Test (BPT)
Status: Enrolling
Updated:  3/2/2016
mi
from
San Francisco, CA
An Online Study of the Reliability of the Brain Performance Test (BPT)
An Online Study of the Reliability of the Brain Performance Test (BPT)
Status: Enrolling
Updated: 3/2/2016
Lumos Labs, Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
mi
from
Beltsville, MD
USDA-ARS, Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
Single Ascending Dose Study of TD-0714 in Healthy Subjects
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Subjects
Status: Enrolling
Updated:  3/3/2016
mi
from
Lincoln, NE
Single Ascending Dose Study of TD-0714 in Healthy Subjects
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Subjects
Status: Enrolling
Updated: 3/3/2016
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated:  3/7/2016
mi
from
Hollywood, FL
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated:  3/7/2016
mi
from
South Miami, FL
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated:  3/7/2016
mi
from
South Miami, FL
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
MRA Clinical Research, LLC
mi
from
South Miami, FL
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated:  3/7/2016
mi
from
Saint Paul, MN
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated:  3/7/2016
mi
from
High Point, NC
Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen
Status: Enrolling
Updated: 3/7/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Click here to add this to my saved trials